Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BenQ Medical Technology Corporation (4116:TWSE), powered by AI.
BenQ Medical Technology Corporation is currently trading at $37.80. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for BenQ Medical Technology Corporation on Alpha Lenz.
View BenQ Medical Technology Corporation's valuation metrics on Alpha Lenz.
“BenQ Medical Technology Corporation's ROE is 7.0%. Explore profitability and growth together.”
Ask for details →BenQ Medical Technology Corporation is a healthcare equipment and technology company specializing in the design, manufacture, and distribution of advanced medical devices and consumables. Established in 1989 and headquartered in Taipei, the company has developed a diverse portfolio that includes products such as operating tables, surgical lights, ultrasound systems, medical display monitors, protective and medical masks, and the proprietary IQOR integrated systems. BenQ Medical Technology serves hospitals, clinics, and healthcare professionals across Taiwan, Mainland China, India, and more than 50 countries worldwide, emphasizing high product quality, technological innovation, and comprehensive international certifications such as GMP, ISO9001, ISO13485, CE, and ETL. In addition to manufacturing, the firm participates in equipment leasing, information software retailing, medical drug sales, and management consultation, further extending its role within the healthcare value chain. Known for its commitment to research and development, BenQ Medical Technology continues to play a significant role in advancing medical infrastructure and supporting the operational needs of major medical institutions globally.
“BenQ Medical Technology Corporation's ROE is 7.0%. Explore profitability and growth together.”
Ask for details →BenQ Medical Technology Corporation (ticker: 4116) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).
The current price is 37.8 with a P/E ratio of -x and P/B of -x.
ROE is 6.95% and operating margin is 6.59%. Annual revenue is $5.3B.